Launch of Hyde Park Discovery between UChicago, Deerfield Management to accelerate research into life-saving treatments ...

Altermagnetism was first theorized in 2019 and experimentally confirmed in 2024 by researchers at Mainz University. It ...

Chinese model’s $6 million price misses some important costs, LinkedIn’s Hoffman helps launch AI cancer drug startup, ...

The global drug discovery services market is set for remarkable growth, with its valuation projected to surge from USD 19.7 ...

Atalanta Therapeutics is building on the growing attention around RNAi-based medicines with its $97 million Series B financing and plans to enter the clinic.

Scientists have unveiled a groundbreaking method to test how thousands of active substances influence cellular metabolism ...

Advances in Experimental Pharmacology and Drug Discovery have encountered a crucial but often overlooked challenge: gender inequality. Despite the pivotal ...

The LinkedIn co-founder is starting Manas AI with “The Emperor of All Maladies” author Siddhartha Mukherjee.

This piece is part of a series that dives deeper into the most prevalent themes of this year’s iteration of our flagship research piece, Charting Disruption. Click to read.

Scientists synthesized inaoside A from mushrooms, unlocking its bioactive potential for functional foods and medicines.

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

Insilico Medcine( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced the first patient has been dosed in the global multicenter Phase I ...